跳到正文

alphaXiv 转发 intology 博客:Locus 自动化分子发现中的 AI 研发

Check out @intology's latest blog on Automating AI R&D for Molecular Discovery

摘要

alphaXiv 转发 intology 关于自动化 AI 研发用于分子发现的博客,并给出发布在 alphaXiv 上的链接。据该博客,自动化研究系统 Locus 可自主开发科学 AI 模型,在分子性质预测、微调 Boltz-2 预测小分子活性以及围绕 BoltzGen、Boltz-2、ESMC、ESMFold2 构建抗体设计流程等任务上,表现优于 SOTA 基线和用于优化这些任务的 LLM 智能体;博客还称其在数据有限时泛化更好、样本效率更高、解方案更多样。

摘要由模型根据原文撰写,以原文为准。

正文 · 原文

Check out @intology's latest blog on Automating AI R&D for Molecular Discovery

Published directly on alphaXiv!

https://alphaxiv.org/abs/2611.automating-ai-rd-for-molecular-discovery

引用Intology@intology
Locus sets the frontier for automating molecular design Our automated research system Locus develops scientific AI models that outperform SOTA expert solutions Unlocking the potential of scientific AI requires leveraging proprietary data. Locus achieves this autonomously 🧵👇 -- We test Locus across a number of tasks related to molecular scoring and design: training molecular property prediction models for a proprietary task, fine-tuning Boltz-2 to predict small-molecule potency, and building antibody design workflows around BoltzGen, Boltz-2, ESMC, and ESMFold2. Each of these settings are real-world AI for science use cases, where tasks are often out-of-distribution for existing foundation models and limited in data, while featuring expensive and noisy evaluators. Compared to state-of-the-art baselines and LLM agents set to optimize these tasks, Locus achieves higher performance. Additionally, Locus generalizes better despite limited data, finds more sample efficient solutions, and explores a higher diversity of solutions.
在 X 查看被引用的帖子

来源:alphaXiv · x.com

引用原文

askalphaxiv. Check out @intology's latest blog on Automating AI R&D for Molecular Discovery[EB/OL]. (2026-11-04)[访问日期]. https://x.com/askalphaxiv/status/2117691354986021325.